PlainPill

Tianeptine

Also known as Stablon

The short answer. More people than not who report on Tianeptine say it helped (63% of 155). It is most often used for mood: 95% of 148 reports say that improved. It is well studied — 18 meta-analyses on PubMed. The most common complaint is addiction.

What users report
63%helped155 reports · high confidence
97 helped35 mixed23 didn't help

From 322 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
18
meta-analyses
42
RCTs
650
papers
Prescription medication. These are self-reported experiences, not dosing or treatment advice. Prescription drugs have real side effects and interactions — start, stop or change them only with a doctor. Share of positive reports is not a measure of safety.

What Tianeptine does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 18 meta-analyses on PubMed ↗ · 42 randomized trials ↗

Mol Psychiatry · 2023 · Meta-analysis / systematic review
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis

Conclusion: Compared to placebo, venlafaxine was associated with a lower incidence of dizziness, while desvenlafaxine, sertraline, and vortioxetine were associated with a higher incidence of nausea/vomiting. In conclusion, desvenlafaxine, paroxetine, venlafaxine, and vortioxetine had reasonable efficacy, acceptability, and tolerability in the treatment of adults with stable MDD.

PubMed 36253442 ↗
J Child Psychol Psychiatry · 2021 · Meta-analysis / systematic review
Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis

Conclusion: Direct pooled evidence supports the efficacy and tolerability of methylphenidate or atomoxetine for treatment of ADHD symptoms in children and youth with ASD. The current review highlights the efficacy of standard ADHD pharmacotherapy for treatment of ADHD symptoms in children and youth with ASD. Consideration of the benefits weighed against the limitations of safety/efficacy data and lack of data evaluating long-term continuation is undertaken to help guide clinical decision-making regarding treatment of co-occurring ADHD symptoms in children and youth with ASD.

PubMed 32845025 ↗
Front Psychiatry · 2020 · Meta-analysis / systematic review
Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment

Conclusion: There is a paucity of data on suicidal ideation/behavior, but paroxetine may increase the risk of suicidality in the treatment of AD and venlafaxine for MDD. Findings from this review must be considered in light of potential limitations, such as the lack of comparative information about many antidepressants, the short-term outcomes and the quality of the available evidence.

PubMed 32982805 ↗
Nephrol Dial Transplant · 2012 · Meta-analysis / systematic review
Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP)

Conclusion: Dose reduction in CKD3-5 is necessary for selegiline, amitriptylinoxide, venlafaxine, desvenlafaxine, milnacipran, bupropion, reboxetine and tianeptine. The evidence on effectiveness of antidepressants versus placebo in patients with CKD3-5, and with the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)-defined depression is insufficient, and in view of the high prevalence, a well-designed RCT is greatly needed.

PubMed 22859791 ↗

Reports to the FDA

Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.

52 reports name a product containing Tianeptine (2015–2025); 39 involved hospitalization or worse. Most often reported:

  • Dependence · 17
  • Death · 9
  • Withdrawal syndrome · 7
  • Anxiety · 6
  • Overdose · 6
  • Loss of consciousness · 6

A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

US legal status (DEA)

Not a scheduled substance, but the DEA lists Tianeptine as a drug of concern. DEA fact sheet ↗

Hidden in other products (FDA)

The FDA found Tianeptine as an undeclared ingredient in 2 products sold as supplements, most recently on 2026-01-09. FDA tainted-products database ↗

US government research funding (NIH)

NIH has funded 1 research project with Tianeptine in the title, $78,599 in total (2022–2023). NIH RePORTER ↗

Dosage people report

We don't list doses for prescription medications. Dosing should only come from a doctor or pharmacist.

Reported side effects

How often each side effect came up across all reports.

addiction ×11withdrawal ×9tolerance ×7headache ×2fatigue ×2brain fog ×2vivid dreams ×1addiction risk ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“It has really improved the quality of my life, more than anything else I have taken.”
HelpedRead the discussion ↗
“tianeptine for example. It has done wonders for my anxiety like no other compound. Now I have to choose between remission of anxiety or buying from some rando lab in China because people ODed on it.”
MixedRead the discussion ↗
“I take 15mg 3x daily, and it keeps me out of depression and in a good mood. It also helps me focus in class more.”
HelpedRead the discussion ↗
“Tianeptine works as a powerful anti-depressant for me and many others at small dosages (~12.5mg).”
HelpedRead the discussion ↗
Read more Tianeptine reviews →
Top discussions (5)

Tianeptine compared

Other options for mood

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate